Can slight variations in lab environments affect the malaria-causing parasite (Plasmodium) and its tolerance to anti-malarial drugs? Griffith University’s Sandra Duffy believes it’s possible.
The PhD candidate in Discovery Biology at the Griffith Institute for Drug Discovery (GRIDD) was invited to write an opinion piece on the subject with GRIDD Principal Research Leader Professor Vicky Avery, who had previously been approached by a reputable journal to explore the topic of best practices for anti-parasitic drug discovery, focusing on malaria.
Routine in vitro culture of Plasmodium falciparum: experimental consequences? published in the latest issue of Trends in Parasitology, is based on Ms Duffy’s observations of the documented variations in culturing the malaria-causing parasite in humans (Plasmodium falciparum) during a decade of work at Griffith.
Having started her PhD in late 2017 to expand her career horizons within an academic setting, Ms Duffy narrowed her PhD focus to an issue that had plagued her
Skip to content
News and other stories about real people, places, and events in Mount Gravatt and nearby suburbs.